• Home
  • 2.0 LPBI Executive Summary
  • 1.0 LPBI Executive Summary
  • Founder’s Vision
  • Journal PharmaceuticalIntelligence.com
  • Portfolio of IP Assets
  • Knowledge PORTALS System (KPS)
  • 1.0 LPBI – 2012-2020 VISTA
  • LPBI Group’s History
  • 2.0 LPBI – 2021-2025 VISION
  • BioMed e-Series
  • Press Coverage
  • Investor Relations
  • Our TEAM
  • Founder’s Bio
  • Funding, Deals & Partnerships
  • 1.0 LPBI Group News
  • 1.0 LPBI CALENDAR
  • 2.0 LPBI Group News
  • Testimonials about LPBI
  • DrugDiscovery @LPBI Group
  • Medical 3D Printing
  • e-VOICES Podcasting
  • LPBI Newsletters
  • Customer Surveys
  • Health Care INVESTOR’s Corner ($)
  • 2021 Summer Internship Portal
  • 2021-2025 Medical Text Analysis (NLP)
  • Artificial Intelligence: Genomics & Cancer
  • Blockchain Transactions Network Ecosystem
  • 1.0 LPBI Brochure
  • 2.0 LPBI Brochure
  • 2.0 LPBI – Calendar of Zooms
  • Coronavirus, SARS-CoV-2 Portal
  • LPBI India
  • SOP Web STAT
  • Synthetic Biology in Drug Discovery
  • Certificate One Year
  • NFT: Redefined Format of IP Assets
  • Audio English-Spanish: BioMed e-Series
  • Five Bilingual BioMed e-Series
  • Press Releases
  • Intangibles CIM
  • Composition of Methods (COM)
  • BioMed Audio Podcast Library @LPBI Group
  • Medical School Education: Use of LPBI Group’s Contents
  • ChatGPT + Wolfram PlugIn
  • Medicine with GPT-4 & ChatGPT
  • AGI, generativeAI, Grok, DeepSeek & Expert Models in Healthcare
  • Multimodal Healthcare Foundation Model
  • Grok 4 aids Exit
  • Cell Therapy in Regenerative Medicine, 2026 and Beyond
  • Contact Us

Leaders in Pharmaceutical Business Intelligence Group, LLC, Doing Business As LPBI Group, Newton, MA

Healthcare analytics, AI solutions for biological big data, providing an AI platform for the biotech, life sciences, medical and pharmaceutical industries, as well as for related technological approaches, i.e., curation and text analysis with machine learning and other activities related to AI applications to these industries.

Feeds:
Posts
Comments

Premalata Pati, PhD, PostDoc in Biological Sciences, Medical Text Analysis with Machine Learning

Premalata Pati, PhD, PostDoc in Biological Sciences, Medical Text Analysis with Machine Learning

https://pharmaceuticalintelligence.com/contributors-biographies/postdoctorants-computer-science-pharmaceutical-sciences-biological-sciences/premalata-pati-phd-postdoc-in-pharmaceutical-sciences-medical-text-analysis-with-machine-learning/

1. Publications on Pharmaceuticalintelligence.com

2. Progress on Text Analysis

Sl No.Date Article Name Article URL  
1 July 6, 2021 Yet another Success Story: Machine Learning to predict immunotherapy responsehttps://pharmaceuticalintelligence.com/2021/07/06/yet-another-success-story-machine-learning-to-predict-immunotherapy-response/
2July 2, 2021 The NIH-funded adjuvant improves the efficacy of India’s COVID-19 vaccinehttps://pharmaceuticalintelligence.com/2021/07/02/the-nih-funded-adjuvant-improves-the-efficacy-of-indias-covid-19-vaccine/
3June 20, 2021Non-toxic antiviral nanoparticles with a broad spectrum of virus inhibitionhttps://pharmaceuticalintelligence.com/2021/06/20/non-toxic-antiviral-nanoparticles-with-a-broad-spectrum-of-virus-inhibition/
4June 10, 2021Despite heated discussion over whether it works, the FDA has approved Aduhelm, bringing a new ray of hope to the Alzheimer’s patients.https://pharmaceuticalintelligence.com/2021/06/10/despite-heated-discussion-over-whether-it-works-the-fda-has-approved-aduhelm-bringing-a-new-ray-of-hope-to-the-alzheimers-patients/
5May 27, 2021Renal tumor macrophages linked to recurrence are identified using single-cell protein activity analysishttps://pharmaceuticalintelligence.com/2021/05/27/renal-tumor-macrophages-linked-to-recurrence-are-identified-using-single-cell-protein-activity-analysis/
6May 4, 2021Machine Learning (ML) in cancer prognosis prediction helps the researcher to identify multiple known as well as candidate cancer diver geneshttps://pharmaceuticalintelligence.com/2021/05/04/machine-learning-ml-in-cancer-prognosis-prediction-helps-the-researcher-to-identify-multiple-known-as-well-as-candidate-cancer-diver-genes/
7April 10, 2021Cryo-EM disclosed how the D614G mutation changes SARS-CoV-2 spike protein structure.https://pharmaceuticalintelligence.com/2021/04/10/cryo-em-disclosed-how-the-d614g-mutation-changes-sars-cov-2-spike-protein-structure/
8March 22, 2021Gene Therapy could be a Boon to Alzheimer’s disease (AD): A first-in-human clinical trial proposedhttps://pharmaceuticalintelligence.com/2021/03/22/gene-therapy-could-be-a-boon-to-alzheimers-disease-ad-a-first-in-human-clinical-trial-proposed/
9February 20, 2021Inhibitory CD161 receptor recognized as a potential immunotherapy target in glioma-infiltrating T cells by single-cell analysishttps://pharmaceuticalintelligence.com/2021/02/20/inhibitory-cd161-receptor-identified-in-glioma-infiltrating-t-cells-by-single-cell-analysis-2/

26 June 2021

LPBI Phase 2: Proof of Concept – Cancer Volume 1 – Chapter 12 Completion

Dropbox– Includes MS Word Files, Text Files, Biological Images File, WORD CLOUDs, Bar Graphs and PPT

URL: https://www.dropbox.com/home/LPBI%20Group/Phase%202%3A%20Proof%20of%20Concept/Premalata%20Pati/Cancer%2C%20Vol%201%20Chapters%207-12/CHAPTER-12

WORD CLOUDs Uploaded in Articles of Chapter 12

Article 12.1- https://pharmaceuticalintelligence.com/2013/05/15/dna-nanotechnology/

Article 12.2- https://pharmaceuticalintelligence.com/2013/01/09/nanotechnology-personalized-medicine-and-dna-sequencing/

Article 12.3- https://pharmaceuticalintelligence.com/2012/12/09/naotech-therapy-for-breast-cancer/

Article 12.4- https://pharmaceuticalintelligence.com/2013/02/07/prostate-cancer-and-nanotecnology/

Article 12.5- Missing

Article 12.6- https://pharmaceuticalintelligence.com/2012/11/23/nanotechnology-tackles-brain-cancer/

Article 12.7- https://pharmaceuticalintelligence.com/2012/11/08/lung-cancer-nsclc-drug-administration-and-nanotechnology/

LPBI Phase 2: Proof of Concept – Cancer Volume 1 – Chapter 11 Completion

Dropbox– Includes MS Word Files, Text Files, Biological Images File, WORD CLOUDs, Bar Graphs and PPT

URL: https://www.dropbox.com/home/LPBI%20Group/Phase%202%3A%20Proof%20of%20Concept/Premalata%20Pati/Cancer%2C%20Vol%201%20Chapters%207-12/CHAPTER-11

WORD CLOUDs Uploaded in Articles of Chapter 11

Article 11.1.1- https://pharmaceuticalintelligence.com/2012/08/27/the-incentive-for-imaging-based-cancer-patient-management/

Article 11.1.2- https://pharmaceuticalintelligence.com/2013/03/10/imaging-biomarkers-is-imaging-based-tissue-characterization/

Article 11.2.1- https://pharmaceuticalintelligence.com/2013/04/10/2013-year-of-the-ultrasound/

Article 11.2.2- https://pharmaceuticalintelligence.com/2012/09/10/imaging-seeing-or-imagining-part-1/

Article 11.2.3- https://pharmaceuticalintelligence.com/2013/05/21/early-detection-of-prostate-cancer-aua-guideline/

Article 11.2.4- https://pharmaceuticalintelligence.com/2012/09/02/todays-fundamental-challenge-in-prostate-cancer-screening-2/

Article 11.2.5- https://pharmaceuticalintelligence.com/2013/01/28/state-of-the-art-in-oncologic-imaging-of-prostate/

Article 11.2.6- https://pharmaceuticalintelligence.com/2013/05/05/from-aua2013-histoscanning-aided-template-biopsies-for-patients-with-previous-negative-trus-biopsies/

Article 11.2.7- https://pharmaceuticalintelligence.com/2013/02/15/on-the-road-to-improve-prostate-biopsy/

Article 11.2.8- https://pharmaceuticalintelligence.com/2013/06/06/ultrasound-imaging-as-an-instrument-for-measuring-tissue-elasticity-shear-wave-elastography-vs-strain-imaging/

Article 11.2.9- https://pharmaceuticalintelligence.com/2012/11/19/what-could-transform-an-underdog-into-a-winner/

Article 11.2.10- https://pharmaceuticalintelligence.com/2013/04/28/ultrasound-based-screening-for-ovarian-cancer/

Article 11.2.11- https://pharmaceuticalintelligence.com/2013/03/22/imaging-guided-cancer-therapy-a-discipline-in-need-of-guidance/

Article 11.3.1- https://pharmaceuticalintelligence.com/2012/10/09/introducing-smart-imaging-into-radiologists-daily-practice/

Article 11.3.2- https://pharmaceuticalintelligence.com/2012/09/29/imaging-seeing-or-imagining-part-2/

Article 11.3.3- https://pharmaceuticalintelligence.com/2012/09/29/imaging-guided-biopsies-is-there-a-preferred-strategy-to-choose/

Article 11.3.4- https://pharmaceuticalintelligence.com/2012/12/16/new-clinical-results-supports-imaging-guidance-for-targeted-prostate-biopsy/

Article 11.3.5- https://pharmaceuticalintelligence.com/2013/01/03/whole-body-imaging-as-cancer-screening-tool-answering-an-unmet-clinical-need/

Article 11.3.6- https://pharmaceuticalintelligence.com/2013/02/03/state-of-the-art-in-oncologic-imaging-of-lymphoma/

Article 11.3.7- https://pharmaceuticalintelligence.com/2012/12/09/a-corner-in-the-medical-imagings-eco-system/

Article 11.4.1- https://pharmaceuticalintelligence.com/2013/05/18/causes-and-imaging-features-of-false-positives-and-false-negatives-on-18f-petct-in-oncologic-imaging/

Article 11.4.2- https://pharmaceuticalintelligence.com/2013/04/15/minimally-invasive-image-guided-therapy-for-inoperable-hepatocellular-carcinoma/

Article 11.4.3- https://pharmaceuticalintelligence.com/2013/01/14/improving-mammography-based-imaging-for-better-treatment-planning/

Article 11.4.4- https://pharmaceuticalintelligence.com/2012/11/04/closing-the-mammography-gap/

Article 11.4.5- https://pharmaceuticalintelligence.com/2013/01/23/state-of-the-art-in-oncologic-imaging-of-lungs/

Article 11.4.6- https://pharmaceuticalintelligence.com/2013/01/19/ovarian-cancer-and-fluorescence-guided-surgery-a-report/

Article 11.5.1- https://pharmaceuticalintelligence.com/2012/12/24/optical-coherent-tomography-emerging-technology-in-cancer-patient-management/

Article 11.5.2- https://pharmaceuticalintelligence.com/2013/01/09/new-imaging-device-bears-a-promise-for-better-quality-control-of-breast-cancer-lumpectomies-considering-the-cost-impact/

Article 11.5.3- https://pharmaceuticalintelligence.com/2013/03/03/virtual-biopsy-is-it-possible/

Article 11.5.4- https://pharmaceuticalintelligence.com/2013/02/22/new-envelopment-in-measuring-mechanical-properties-of-tissue/

18 June 2021

LPBI Phase 2: Proof of Concept – Cancer Volume 1 – Chapter 10 Completion

Dropbox– Includes MS Word Files, Text Files, Biological Images File, WORD CLOUDs, Bar Graphs and PPT

URL: https://www.dropbox.com/home/LPBI%20Group/Phase%202%3A%20Proof%20of%20Concept/Premalata%20Pati/Cancer%2C%20Vol%201%20Chapters%207-12/CHAPTER-10

WORD CLOUDs Uploaded in Articles of Chapter 10

Article 10.1- https://pharmaceuticalintelligence.com/2013/04/21/mesothelin-an-early-detection-biomarker-for-cancer-by-jack-andraka/

Article 10.2- https://pharmaceuticalintelligence.com/2012/12/25/stanniocalcin-a-cancer-biomarker/

Article 10.3- https://pharmaceuticalintelligence.com/2012/12/24/breast-cancer-genomic-profiling-to-predict-survival-combination-of-histopathology-and-gene-expression-analysis/

Article 10.4- https://pharmaceuticalintelligence.com/2012/10/24/biomarker-tool-development-for-early-diagnosis-of-pancreatic-cancer-van-andel-institute-and-emory-university/

Article 10.5- https://pharmaceuticalintelligence.com/2012/05/17/early-biomarker-for-pancreatic-cancer-identified/

Article 10.6- https://pharmaceuticalintelligence.com/2012/09/18/head-and-neck-cancer-studies-suggest-alternative-markers-more-prognostically-useful-than-hpv-dna-testing/

Article 10.7- https://pharmaceuticalintelligence.com/2013/05/29/opens-exome-service-for-rare-diseases-advanced-cancer-mayo-clinics-oncospire/

Article 10.8- https://pharmaceuticalintelligence.com/2013/05/23/in-search-of-clarity-on-prostate-cancer-screening-post-surgical-followup-and-prediction-of-long-term-remission/

LPBI Phase 2: Proof of Concept – Cancer Volume 1 – Chapter 9 Completion

Dropbox– Includes MS Word Files, Text Files, Biological Images File, WORD CLOUDs, Bar Graphs and PPT

URL: https://www.dropbox.com/home/LPBI%20Group/Phase%202%3A%20Proof%20of%20Concept/Premalata%20Pati/Cancer%2C%20Vol%201%20Chapters%207-12/CHAPTER-9

WORD CLOUDs Uploaded in Articles of Chapter 9

Article 9.1- https://pharmaceuticalintelligence.com/2013/05/21/early-detection-of-prostate-cancer-aua-guideline/

Article 9.2- https://pharmaceuticalintelligence.com/2013/05/20/testing-for-multiple-genetic-mutations-via-ngs-for-patients-very-strong-family-history-of-breast-ovarian-cancer-diagnosed-at-young-ages-negative-on-brca-test/

Article 9.3- https://pharmaceuticalintelligence.com/2013/05/16/a-blood-test-to-identify-aggressive-prostate-cancer-a-discovery-sri-international-menlo-park-ca/

Article 9.4- https://pharmaceuticalintelligence.com/2013/06/13/combining-nanotube-technology-and-genetically-engineered-antibodies-to-detect-prostate-cancer-biomarkers/

Article 9.5- https://pharmaceuticalintelligence.com/2012/09/23/warning-signs-may-lead-to-better-early-detection-of-ovarian-cancer/

Article 9.6- https://pharmaceuticalintelligence.com/2012/10/16/knowing-the-tumors-size-and-location-could-we-target-treatment-to-the-roi-by-applying-imaging-guided-intervention/

13 June 2021

LPBI Phase 2: Proof of Concept – Cancer Volume 1 – Chapter 8 Completion

Dropbox– Includes MS Word Files, Text Files, Biological Images File, WORD CLOUDs, Bar Graph and PPT

URL:

https://www.dropbox.com/home/LPBI%20Group/Phase%202%3A%20Proof%20of%20Concept/Premalata%20Pati/Cancer%2C%20Vol%201%20Chapters%207-12/CHAPTER-8

WORD CLOUDs Uploaded in Articles of Chapter 8

Article 8.1- https://pharmaceuticalintelligence.com/2013/05/21/prostate-cancer-molecular-diagnostic-market-the-players-are-sri-intl-genomic-health-wcleveland-clinic-myriad-genetics-wucsf-genomedx-and-biotheranostics/

Article 8.2- https://pharmaceuticalintelligence.com/2012/09/02/todays-fundamental-challenge-in-prostate-cancer-screening-2/

Article 8.3- https://pharmaceuticalintelligence.com/2012/07/31/prostate-cancers-plunged-after-uspstf-guidance-will-it-happen-again/

Article 8.4- https://pharmaceuticalintelligence.com/2012/05/27/new-prostate-cancer-screening-guidelines-face-a-tough-sell-study-suggests/

Article 8.5- https://pharmaceuticalintelligence.com/2012/12/01/diagnosing-lung-cancer-in-exhaled-breath-using-gold-nanoparticles/

11 June 2021

LPBI Phase 2: Proof of Concept – Cancer Volume 1 – Chapter 7 Completion

Dropbox– Includes MS Word Files, Text Files, Biological Images File, WORD CLOUDs, Bar Graph and PPT

URL: https://www.dropbox.com/home/LPBI%20Group/Phase%202%3A%20Proof%20of%20Concept/Premalata%20Pati/Cancer%2C%20Vol%201%20Chapters%207-12/CHAPTER-7

WORD CLOUDs Uploaded in Articles of Chapter 7

Article 7.1.1- https://pharmaceuticalintelligence.com/2013/01/12/harnessing-personalized-medicine-for-cancer-management-prospects-of-prevention-and-cure-opinions-of-cancer-scientific-leaders-httppharmaceuticalintelligence-com/

Article 7.1.2- https://pharmaceuticalintelligence.com/2012/11/20/personalized-medicine-based-cure-for-cancer-might-not-be-far-away/

Article 7.1.3- https://pharmaceuticalintelligence.com/2013/01/07/personalized-medicine-gearing-up-to-tackle-cancer/

Article 7.1.4- https://pharmaceuticalintelligence.com/2013/03/25/tel-aviv-sourasky-medical-center-cancer-prevention-center-excellent-example-for-adopting-prevention-of-cancer-as-a-mean-of-fighting-it/

Article 7.1.5- https://pharmaceuticalintelligence.com/2013/01/10/inspiration-from-dr-maureen-cronins-achievements-in-applying-genomic-sequencing-to-cancer-diagnostics/

Article 7.1.6- https://pharmaceuticalintelligence.com/2012/12/01/personalized-medicine-cancer-cell-biology-and-minimally-invasive-surgery-mis/

Article 7.2.1- https://pharmaceuticalintelligence.com/2012/10/29/cancer-genomics-leading-the-way-by-cancer-genomics-program-at-uc-santa-cruz/

Article 7.2.2- https://pharmaceuticalintelligence.com/2013/04/23/whole-exome-somatic-mutations-analysis-of-malignant-melanoma-contributes-to-the-development-of-personalized-cancer-therapy-for-this-disease/

Article 7.2.3- https://pharmaceuticalintelligence.com/2013/04/22/genotype-based-analysis-for-cancer-therapy-using-large-scale-data-modeling-nayoung-kim-phdc/

Article 7.2.4- https://pharmaceuticalintelligence.com/2013/04/21/cancer-genomic-precision-therapy-digitized-tumors-genome-wgsa-compared-with-genome-native-germ-line-flash-frozen-specimen-and-formalin-fixed-paraffin-embedded-specimen-needed/

Article 7.2.5- https://pharmaceuticalintelligence.com/2013/01/13/leaders-in-genome-sequencing-of-genetic-mutations-for-therapeutic-drug-selection-in-cancer-personalized-treatment-part-2/

Article 7.2.6- https://pharmaceuticalintelligence.com/2013/03/27/ethical-concerns-in-personalized-medicine-brca12-testing-in-minors-and-communication-of-breast-cancer-risk/

Article 7.3.1- https://pharmaceuticalintelligence.com/2013/05/09/the-development-of-sirna-based-therapies-for-cancer/

Article 7.3.2- https://pharmaceuticalintelligence.com/2012/10/26/mrna-interference-with-cancer-expression/

Article 7.3.3- https://pharmaceuticalintelligence.com/2013/05/07/cd47-target-therapy-for-cancer/

Article 7.3.4- https://pharmaceuticalintelligence.com/2013/04/06/targeting-mitochondrial-bound-hexokinase-for-cancer-therapy/

Article 7.3.5- https://pharmaceuticalintelligence.com/2012/11/14/gsk-for-personalized-medicine-using-cancer-drugs-needs-alacris-systems-biology-model-to-determine-the-in-silico-effect-of-the-inhibitor-in-its-virtual-clinical-trial/

Article 7.3.6- https://pharmaceuticalintelligence.com/2012/10/16/personalized-pancreatic-cancer-treatment-option/

Article 7.3.7- https://pharmaceuticalintelligence.com/2013/05/30/new-scheme-to-routinely-test-patients-for-inherited-cancer-genes/

Article 7.3.8- https://pharmaceuticalintelligence.com/2013/11/01/targeting-untargetable-proto-oncogenes/

Article 7.3.9- https://pharmaceuticalintelligence.com/2014/03/05/the-future-of-translational-medicine-with-smart-diagnostics-and-therapies-pharmacogenomics/#comment-54338

Article 7.4.1- https://pharmaceuticalintelligence.com/2013/05/25/personalized-medicine-and-colon-cancer/

Article 7.4.2- https://pharmaceuticalintelligence.com/2012/09/10/comprehensive-genomic-characterization-of-squamous-cell-lung-cancers/

Article 7.4.3- https://pharmaceuticalintelligence.com/2012/09/10/targeted-tumor-penetrating-sirna-nanocomplexes-for-credentialing-the-ovarian-cancer-oncogene-id4/

Article 7.4.4- https://pharmaceuticalintelligence.com/2012/06/19/cancer-and-bone-low-magnitude-vibrations-help-mitigate-bone-loss-5-2/

Article 7.4.5- https://pharmaceuticalintelligence.com/2012/05/27/new-prostate-cancer-screening-guidelines-face-a-tough-sell-study-suggests/

Share this:

  • Share on X (Opens in new window) X
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Share on Facebook (Opens in new window) Facebook
  • Print (Opens in new window) Print
  • Email a link to a friend (Opens in new window) Email

Like this:

Like Loading...

  • Follow Blog via Email

    Enter your email address to follow this blog and receive notifications of new posts by email.

    Join 2,058 other subscribers
  • Recent Posts

    • Grok thinks like PhDs – Hybrid Model for Autonomous Update of Doctoral Dissertations with Original PhD Student Author editing and acceptance of Grok’s updated output. 3rd Joint article, a pilot study for Validation of an Autonomous Journal Articles Updating System (AJAUS) tested on Autonomous Update of Aviva Lev-Ari, PhD, RN Doctoral Thesis, UC, Berkeley, 1983. January 31, 2026
    • 2026 World Economic Forum, 1/19 – 1/23/2026, Davos, Switzerland, LPBI Group’s KOLs interpretation of AI in Health Videos January 24, 2026
    • Evolving LPBI Group’s Portfolio of Intellectual Properties (IP): From 2021 Vision to 2026 Reality January 12, 2026
    • Aviva Lev-Ari, PhD, RN – Biography ->> Grokepedia Entry January 11, 2026
    • List of Articles included in the Article SELECTION from Collection of Aviva Lev-Ari, PhD, RN Scientific Articles on PULSE on LinkedIn.com for Training Small Language Models (SLMs) in Domain-aware Content of Medical, Pharmaceutical, Life Sciences and Healthcare by 15 Subjects Matter January 10, 2026
    • Article SELECTION from Collection of Aviva Lev-Ari, PhD, RN Scientific Articles on PULSE on LinkedIn.com for Training Small Language Models (SLMs) in Domain-aware Content of Medical, Pharmaceutical, Life Sciences and Healthcare by 15 Subjects Matter January 10, 2026
    • Collection of Aviva Lev-Ari, PhD, RN Scientific Articles on PULSE on LinkedIn.com January 10, 2026
    • The youngest leader in AI in Health: Tanishq Mathew Abraham, Ph.D. (@iScienceLuvr) January 8, 2026
    • 2026 Grok Multimodal Causal Reasoning on Proprietary Cariovascular Corpus: From 2021 Wolfram NLP Baseline to Thousands of Novel Relationships – A Second Head-to-Head Validation of LPBI’s Domain-Aware Training Advantage January 6, 2026
    • Workflow for Dynamic Linkage and Transition between two Authoring Systems: LPBI Group’s WordPress.com Multi-Authors Authoring System and Microsoft PowerPoint product for Slide show presentation – Part 10.1 in Composition of Methods January 6, 2026
  • Archives

  • Categories

  • Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    • 1 2012pharmaceutical
    • 1 sjwilliamspa

Powered by WordPress.com.

WPThemes.


%d